Project documents | Beremagene geperpavec for treating skin wounds associated with dystrophic epidermolysis bullosa [ID3959] | Guidance | NICE

Documents

Documents created during the development process.

Invitation to participate

Final scope (PDF 117 KB)

Published:

10 February 2025
NICE's response to comments on the draft scope and provisional stakeholder list (PDF 229 KB)

Published:

10 February 2025
Equality impact assessment (scoping) (PDF 105 KB)

Published:

10 February 2025
Final stakeholder list (PDF 121 KB)

Published:

09 March 2025

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators

Draft scope post referral (PDF 165 KB)

Published:

03 December 2024
Draft matrix post referral (PDF 101 KB)

Published:

03 December 2024

Topic selection

Supporting documentation (MSWord 43 KB)

Published:

14 June 2023
HST checklist (MSWord 45 KB)

Published:

12 January 2024

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators

Draft matrix post referral (PDF 159 KB)

Published:

09 November 2022
Draft scope post referral (PDF 165 KB)

Published:

09 November 2022